🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety and efficacy of long-term administration of aripiprazo...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00606320
Treatments Being Tested
SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06060886
Treatments Being Tested
The overall purpose is to determine research based 'next-steps' for outpati...
Status
Completed
Location
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Start Date
2012-12
Trial ID
NCT01421342
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
6th affiliated hospital, Peking University
Start Date
2018-04-09
Trial ID
NCT03487770
Treatments Being Tested
Prolactin is a hormone that naturally occurs in the body. Some women taking...
Status
Completed
Location
Maryland Psychiatric Research Center
Start Date
2011-01
Trial ID
NCT01338298
Treatments Being Tested
The purpose of this study is to gather information about the steady-state p...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02087579
The purpose of this study was to determine the accuracy of IEM detection by...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-21
Trial ID
NCT02091882
Treatments Being Tested
This is an open-label study consisting of a screening period, a conversion/...
Status
Terminated
Location
Study Site
Start Date
2010-07
Trial ID
NCT01122927
Treatments Being Tested
To evaluate and compare the relative plasma bioavailability and therefore t...
Status
Completed
Location
Future Research Center (FRC)
Start Date
2021-02-14
Trial ID
NCT05532254
Treatments Being Tested
A Clinical Study that will look at an investigational medication, SEP-36385...
Status
Completed
Location
Woodland International Research Group
Start Date
2022-11-15
Trial ID
NCT05542264
Treatments Being Tested